ABSTRACT
Introduction Recent research underscores the exceptionally young age distribution of Covid-19 deaths in the United States compared with international peers. This brief characterizes how high levels of Covid mortality at midlife ages (45-64) are deeply intertwined with continuing racial inequity in Covid-19 mortality.
Methods Mortality data from Minnesota in 2020-2022 were analyzed in June 2022. Death certificate data and published vaccination rates in Minnesota allow vaccination and mortality rates to be observed with greater age and temporal precision than national data.
Results Black, Hispanic, and Asian adults under age 65 were all more highly vaccinated than white populations of the same ages during most of Minnesota’s substantial and sustained Delta surge and all of the subsequent Omicron surge. However, white mortality rates were lower than those of all other groups. These disparities were extreme; at midlife ages (ages 45-64), during the Omicron period, more highly-vaccinated populations had COVID-19 mortality that was 164% (Asian-American), 115% (Hispanic), or 208% (Black) of white Covid-19 mortality at these ages. In Black, Indigenous, and People of Color (BIPOC) populations as a whole, Covid-19 mortality at ages 55-64 was greater than white mortality at 10 years older.
Conclusions This discrepancy between vaccination and mortality patterning by race/ethnicity suggests that, if the current period is a “pandemic of the unvaccinated,” it also remains a “pandemic of the disadvantaged” in ways that can decouple from vaccination rates. This result implies an urgent need to center health equity in the development of Covid-19 policy measures.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was funded by the Eunice Kennedy Shriver National Institute on Child Health and Human Development (P2CHD041023, F31HD107980), the National Institute on Aging (P30AG066613, R01AG060115-04S1), the Robert Wood Johnson Foundation (Grant #77521), and the University of Minnesota School of Public Health. The interpretations, conclusions, and recommendations in this work are those of the authors and do not necessarily represent the views of the National Institutes of Health or the Robert Wood Johnson Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the University of Minnesota waived ethical approval for this work. The University of Minnesota IRB's study identifier for this study's exemption from full review is STUDY00012527.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
We updated the analysis to include deaths during the period dominated by Omicron variants (January 1, 2022 - April 30, 2022). Previous versions included deaths only through December 31, 2021.
Data Availability
All data produced are available online at https://osf.io/bxjkh/?view_only=80e912ce2b624ab7a78e51754c3952e3
https://osf.io/bxjkh/?view_only=80e912ce2b624ab7a78e51754c3952e3